MENU
LGND
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ligand Pharmaceuticals (LGND) Earnings Date & Reports

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

LGND is expected to report earnings to fall 33.33% to $2.06 per share on March 04

Ligand Pharmaceuticals LGND Stock Earnings Reports
Q4'25
Est.
$2.06
Q3'25
Beat
by $1.16
Q2'25
Beat
by $0.17
Q1'25
Beat
by $0.11
Q4'24
Beat
by $0.09
The last earnings report on November 06 showed earnings per share of $3.09, beating the estimate of $1.93. With 220.45K shares outstanding, the current market capitalization sits at 3.96B.
View a ticker or compare two or three
LGND
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LGND showed earnings on November 06, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a biotechnology company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
555 Heritage Drive
Phone
+1 858 550-7500
Employees
58
Web
https://www.ligand.com